Zimmer proposes divestitures for EU regulators in Biomet deal
December 4, 2014 by Brad Perriello
Zimmer said today that it’s proposing to sell of some of its knee and elbow assets in Europe to satisfy anti-trust regulators on the European Commission about its pending, $13.35 billion acquisition of cross-town orthopedics rival Biomet.
“Zimmer has been working closely with the EC to develop a mutually-acceptable solution to address the discrete concerns identified by the EC in its preliminary assessment of the proposed acquisition of Biomet,” the company said. Read more
China, South Korea OK Medtronic's $43B Covidien buy
December 4, 2014 by Mark Hollmer
Chinese regulatory authorities have signed off on the planned $43 billion merger between Medtronic and Covidien, a major milestone as both companies push to conclude the transaction by end of the 2015 1st quarter.
The Chinese Ministry of Commerce’s clearance of the massive deal comes in tandem with the South Korean Fair Trade Commission’s acceptance of the M&A agreement, Medtronic said today. As well, the companies now have all necessary antitrust clearances in hand. Read more
BTG to buy PneumRx for up to $475m
December 4, 2014 by MassDevice
BTG, the healthcare group best known for treating rattlesnake bites and varicose veins, is expanding into lung care by buying a California firm that has developed a device to prop open airways.
The British company said today that it would pay an initial $230 million and up to $245 million in performance-related milestones to acquire privately-owned PneumRx. Read more
BD prices $6.2B bond issue for CareFusion buy
December 5, 2014 by Brad Perriello
Becton Dickinson priced a debt offering yesterday that it plans to use to consummate its $12.2 billion offer for CareFusion.
The offering entails 5 sets of senior unsecured bonds worth a collective $6.2 billion. Read more
Danaher's Leica division closes Devicor Medical buy
December 4, 2014 by Brad Perriello
Danaher said today that its Leica Biosystems division closed its buyout of Devicor Medical Products, a developer of breast biopsy products.
Leica Biosystems specializes in automated cancer diagnostics. Financial terms were not disclosed. Read more
